4-(Polyalkoxyphenyl)-2-pyrrolidones
AssigneeSchering Corporation
InventorsRalph Schmiechen, Reinhard Horowski, Dieter Palenschat, Gert Paschelke, Helmut Wachtel, Wolfgang Kehr
Life of this patent
Estimating the term…
Loading patent…
AssigneeSchering Corporation
InventorsRalph Schmiechen, Reinhard Horowski, Dieter Palenschat, Gert Paschelke, Helmut Wachtel, Wolfgang Kehr
Estimating the term…
4-(Polyalkoxyphenyl)-2-pyrrolidones of the formula ##STR1## wherein R.sub.1 and R.sub.2 each are hydrocarbon of up to 18 carbon atoms or alkyl of 1-5 carbon atoms substituted by halogen, OH, COOH, alkoxy, alkoxycarbonyl, carboxamido or amino or collectively are alkylene of 1-3 carbon atoms, R.sub.3 is H or OCH.sub.3, R.sub.4 is H, alkyl, aryl or acyl and X is O or S possess neuropsychotropic activity. The compounds wherein X is O are produced by saponifying and decarboxylating a corresponding 2-pyrrolidone-3-carboxylic acid alkyl ester or cyclizing a corresponding 3-phenyl-4-aminobutyric acid or alkyl ester thereof. The pyrrolidones are converted to corresponding thiopyrrolidones in a conventional manner, e.g., by reaction with phosphorous pentasulfide in the presence of base.
A pharamaceutical composition for the treatment of neurological and psychic disorders responsive to chlorpromazine therapy and characterized by one or more of the symptoms of anxiety, hostility, agression, withdrawal, hallucination, thought-disturbances, delusion and agitation, comprising, in admixture with a pharmaceutically acceptable carrier, an amount per dosage unit from 0.05-20 mg. effective to reduce the symptoms of such disorders, of a 4-(polyalkoxyphenyl)-2-pyrrolidone of the formula ##STR49## wherein R.sub.1 and R.sub.2 each are hydrocarbon of up to 18 carbon atoms or alkyl of 1-5 carbon atoms substituted by one or more halogen atoms or by one hydroxy, carboxy, alkoxy of 1-5 carbon atoms, alkoxycarbonyl of 1-5 carbon atoms in the alkoxy group, carboxamido, alkylcarboxamido, dialkylcarboxamido, carboxycyclicamido, amino, alkylamino, dialkyl or alkyleneimino, wherein alkyl in each instance is of 1-5 carbon atoms and wherein the nitrogen atom of the cyclicamido and alkyleneimino groups is a ring member of alkyleneimino of 4 to 7 members or R.sub.1 or R.sub.2 collectively are alkylene of 1-3 carbon atoms;
Dependencies are inferred from the claim text.